Preventability of drug-related harms part I: A systematic review

Drug Safety

Volumn 33, Issue 11, 2010, Pages 985-994

  Ferner, Robin E ^a,b   Aronson, Jeffrey K ^c  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adverse drug reactions; Pharmacovigilance

Indexed keywords

DRUG;

CONSENSUS DEVELOPMENT; DRUG INDUCED DISEASE; HUMAN; INFORMATION TECHNOLOGY; MEDICATION ERROR; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW;

CONSENSUS; DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; STANDARD OF CARE;

EID: 77957803169     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11538270-000000000-00000     Document Type: Review

References (67)

1. Aronson JK, Ferner RE. Preventability of drug-related harms-part II: proposed criteria, based on frameworks that classify adverse drug reactions. Drug Saf 2010; 33 (11): 995-1002
2. Goettler M, Schneeweiss S, Hasford J. Adverse drug reac-tion monitoring: cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 Suppl. 3: S79-90
3. Melmon KL. Preventable drug reactions: causes and cures. N Engl J Med 1971; 284 (24): 1361-8
4. Burnum JF. Preventability of adverse drug reactions. Ann Intern Med 1976; 85 (1): 80-1
5. Takata GS, Mason W, Taketomo C, et al. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics 2008; 121: e927-35
6. Bigby J, Dunn J, Goldman L, et al. Assessing the prevent-ability of emergency hospital admissions. Am J Med 1987; 3: 1031-6
7. Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med 1988; 109 (7): 582-9
8. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170 (11): 1678-86
9. Baker GR. e-Appendix 3: brief description of clinical details of adverse events occurring in 255 patients, by corresponding maximum degree of preventability [online]. Available from URL: http://www.cmaj.ca/cgi/data/170/11/ 1678/DC3/1 [Accessed 2009 Jun 21]
10. Morris CJ, Cantrill JA. Preventing drug-related morbidity: the development of quality indicators. J Clin Pharm Ther 2003; 28 (4): 295-305
11. Buetow SA, Sibbald B, Cantrill JA, et al. Appropriateness in health care: application to prescribing. Soc Sci Med 1997; 45 (2): 261-71
12. McDowell SE, Ferner HS, Ferner RE. The pathophysiology of medication errors: how and where they arise. Br J Clin Pharmacol 2009; 67 (6): 605-13
13. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140 (10): 795-801
14. Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60 (17): 1750-9
15. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228 (2): 83-90
16. Ho PM, Maddox TM, Wang L, et al. Risk of adverse out-comes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301 (9): 937-44
17. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 1995; 274 (1): 29-34
18. Gurwitz JH, Field TS, Avorn J, et al. Incidence and pre-ventability of adverse drug events in nursing homes. Am J Med 2000; 109 (2): 87-94
19. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289 (9): 1107-16
20. Ferner RE. The epidemiology of medication errors: the methodological difficulties. Br J Clin Pharmacol 2009; 67 (6): 614-20
21. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975; 234: 1236-41
22. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329 (7456): 15-9
23. van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17: 365-71
24. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31 (6): 545-56
25. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency de-partment visits or hospital admissions. Eur J Clin Pharmacol 1999; 54 (12): 959-63
26. Darchy B, Le Miere E, Figueredo B, et al. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 1999; 159 (1): 71-8
27. Thomas EJ, Brennan TA. Incidence and types of pre-ventable adverse events in elderly patients: population based review of medical records. BMJ 2000; 320: 741-4
28. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008; 178 (12): 1563-9
29. Sari AB, Cracknell A, Sheldon TA. Incidence, preventability and consequences of adverse events in older people: results of a retrospective case-note review. Age Ageing 2008; 37 (3): 265-9
30. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA 2001; 286 (4): 415-20
31. Brennan TA, Leape LL, Laird NM, et al. Incidence of ad-verse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324 (6): 370-6
32. Brennan TA, Hebert LE, Laird NM, et al. Hospital char-acteristics associated with adverse events and substandard care. JAMA 1991; 265 (24): 3265-9
33. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; 2 (8402): 564-7
34. Hartwig SC, Siegel J, Schneider PJ. Preventability and se-verity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49 (9): 2229-32
35. Kelly WN. Potential risks and prevention: part1.Fatal adverse drug events. Am J Health Syst Pharm 2001; 58 (14): 1317-24
36. Kelly WN. Potential risks and prevention: part 2. Drug-induced permanent disabilities. Am J Health Syst Pharm 2001; 58 (14): 1325-9
37. Marcellino K, Kelly WN. Potential risks and prevention: part 3. Drug-induced threats to life. Am J Health Syst Pharm 2001; 58 (15): 1399-405
38. Kelly WN. Potential risks and prevention: part 4. Reports of significant adverse drug events. Am J Health Syst Pharm 2001; 58 (15): 1406-12
39. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27 (6): 538
40. Gholami K, Shalviri G. Factors associated with prevent-ability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33 (2): 236-40
41. Ruiz B, Garca M, Aguirre U, et al. Factors predicting hospital readmissions related to adverse drug reactions. Eur J Clin Pharmacol 2008; 64 (7): 715-22
42. Leendertse AJ, Egberts ACG, Stoker LJ, et al., for the HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168 (17): 1890-6
43. Kunac DL, Reith DM. Preventable medication-related events in hospitalised children in New Zealand. N Z Med J 2008; 121: 17-32
44. Ducharme MM, Boothby LA. Analysis of adverse drug reactions for preventability. Int J Clin Pract 2007; 61 (1): 157-61
45. Dormann H, Neubert A, Criegee-Rieck M, et al. Re-admissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 2004; 255: 653-63
46. Snyder RA, Abarca J, Meza JL, et al. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index. Pharmacoepidemiol Drug Saf 2007; 16: 1006-13
47. Rawlins MD. Clinical pharmacology: adverse reactions to drugs. BMJ (Clin Res Ed) 1981; 282: 974-6
48. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28 (10): 851-70
49. Jonville-Bera AP, Saissi H, Bensouda-Grimaldi L, et al. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre. Drug Saf 2009; 32 (5): 429-40.
50. Anonymous. Failings in treatment advice, SPCs and black triangles. Drug Ther Bull 2001. 39:4, 25-7.
51. Bates DW, O'Neil AC, Boyle D, et al. Potential identifia-bility and preventability of adverse events using information systems. J Am Med Inform Assoc 1994; 1 (5): 404-11
52. Bobb A, Gleason K, Husch M, et al. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 2004; 164 (7): 785-92
53. Kuo GM, Phillips RL, Graham D, et al. Medication errors reported by US family physicians and their office staff. Qual Saf Health Care 2008; 17: 286-90
54. van der Sijs H, Vulto A, Berg M. Overriding of drug safety alerts in Computerized Physician Order Entry. J Am Med Inform Assoc 2006; 13: 138-47
55. Silverman JB, Stapinski CD, Churchill WW, et al. Multi-faceted approach to reducing preventable adverse drug events. Am J Health Syst Pharm 2003; 60 (6): 582-6
56. Aronson JK. Medication errors: definitions and classifica-tion. Br J Clin Pharmacol 2009; 67 (6): 599-604
57. Beers MH, Ouslander JG, Rollingher I, et al. Explicit cri-teria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151 (9): 1825-32
58. Beers MH. Explicit criteria for determining potentially in-appropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531-6
59. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163 (22): 2716-24
60. Budnitz DS, Shehab N, Kegler SR, et al. Medication use leading to emergency department visits for adverse drug eventsinolder adults. Ann Intern Med 2007; 147 (11): 755-65
61. Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002; 24 (10): 1595-613
62. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Health Syst Pharm 1990; 47: 533-43
63. MacKinnon NJ, Hepler CD. Indicators of preventable drug-related morbidity in older adults: 2. Use within a managed care organization. J Manag Care Pharm 2003; 9 (2): 134-41
64. Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12 (4): 280-5
65. Baena MI, Marin R, Martinez Olmos J, et al. Nuevos cri-terios para determiner la evidabilidad de los problemas relacionados con los medicamentos. Una revision actuali-zada a partir de la experiencia con 2558 personas. Pharm Care Esp 2002; 4: 393-6
66. Olivier P, Caron J, Haramburu F, et al. Validation d'une echelle de mesure: exemple de l'echelle française d'evit-abilite des effets indesirables medicamenteux. Therapie 2005; 60 (1): 39-45
67. Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36 (7-8): 1238-48